Table 2 Perioperative management
Population (n = 187) | SARS-CoV-2 negative (n = 52) | SARS-CoV-2 positive (n = 135) | |
|---|---|---|---|
General anesthesia | 173 (93.5) | 52 (100.0) | 121 (91.0) |
Rapid Sequence Induction | 113 (86.3) | 38 (90.5) | 75 (84.3) |
Videolaryngoscopy | 110 (87.3) | 33 (86.6) | 77 (87.5) |
Closed system for endotracheal suction | 28 (37.3) | 8 (28.6) | 20 (42.6) |
Total Intra-Venous Anesthesia | 57 (33.1) | 17 ( 33.3) | 40 ( 33.0) |
Mechanical ventilation | 164 (88.2) | 46 (88.5) | 118 (88.1) |
Mechanical ventilation characteristics | |||
Tidal volume, ml.kg−1 PBW | 6 [6; 7] | 7 [6; 7] | 6 [6; 7] |
PEEP, cmH2O | 6 [5; 8] | 5 [5; 6] | 6 [5; 8] |
FiO2, % | 50 [44; 60] | 59 [46; 60] | 50 [43; 64] |
Peak pressure, cmH2O | 22 [18; 26] | 20 [18; 23] | 22 [18; 27] |
Unplanned recruitment maneuver | 16 (10.6) | 3 (6.7) | 13 (12.3) |
Intra-operative transfusion | 22 (12.0) | 8 (15.4) | 14 (10.7) |
Totally intravenous fluids, mL | 1000 [500; 1600] | 1100 [500; 2000] | 1000 [500; 1536] |
Need of vasoactive drugs | 79 (43.9) | 25 (49.0) | 54 (41.9) |
Loco-Regional anesthesia | 25 (14.5) | 5 (9.6) | 21 (16.9) |
Surgery length, min | 70 [37; 114] | 60 [26; 104] | 70 [40; 120] |
Surgery length, min | |||
[0; 30] | 40 (27.0) | 17 (35.4) | 23 (23.0) |
[30; 60] | 45 (30.4) | 11 (22.9) | 34 (34.0) |
[60; 120] | 29 (19.6) | 10 (20.8) | 19 (19.0) |
[120; 540] | 34 (23.0) | 10 (20.8) | 24 (24.0) |